IMCD with 17% Operating EBITA Growth in first three Months of 2018, partially driven by Acquisitions
Specialty Chemicals distributor IMCD N.V. (Rotterdam, The Netherlands) reported on the performance in the first three months of 2018. Gross Profit grew by 23 % to EUR 128.3 mn (+27% on a constant currency basis) and Operating EBITA 17% to EUR 49.9 mn (+23 % on a constant currency basis) . This resulted in Cash Earnings per Share (i.e. before amortisation) of EUR 0.67, an increase of 20% when compared with result for the first three months of 2017. Free cash flow decreased by 25%, from EUR 43.3 mn in Q1-2017 toEUR 32.4 mn, as the higher opera ting EBITA was offset by higher working capital investments.
The (geographical) operating segments showed a mixed picture. EMEA (defines as Europe, Turkey and Africa) posted revenues of EUR 315.6 mn (up 8% as reported or 9% on a constant currency basis). Operating EBITA in the region grew from EUR 30.7 mn to EUR 34.3 mn, up 12% as reported and 14% when adjusted for currency effects. Asia-Pacific generated revenues of EUR 80.8 mn (down from EUR 82.2 mn, or -2% as reported, but up 9% in constant currency). Operating EBITA in that region was virtually flat at EUR 7.6 mn compared with EUR 7.5 mn in Q1-2017, up 1% as reported and 12% when adjusted for currency effects. In the America the effect of two acqusitions, Bossco Industries (July 2017) and L.V. Lomas (September 2017) can be seen in the revenue figure of EUR 169.9 mn, up 79% (or 107% at constant currency) from the EUR 95.1 mn in the same period of 2017. Operating EBITA was EUR 12.4 mn, up 56% from the EUR 8.0 mn in the previous year (a growth of 80% at constant currency).
Structural cost increased, resulting in a Operating EBITA for the “holding companies” (i.e. the head office in Rotterdam and regional head offices in Sinagpore and New Jersey, United States of America) of EUR -4.3 mn (compared to EUR -3.4 mn in Q1-2017).
The original press release can be accessed via the link http://hugin.info/164110/R/2191325/848314.pdf
Source: IMCD press release
HGE / DCG – 09.05.2018